Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 4:07 AM ET

Pharmaceuticals

Company Overview of Aptalis Pharma Canada Inc.

Company Overview

Aptalis Pharma Canada Inc. develops therapies for cystic fibrosis and gastrointestinal disorders in the United States, the European Union, and Canada. It manufactures and commercializes pharmaceutical products, including ZENPEP, ULTRASE, and VIOKASE products for the treatment of exocrine pancreatic insufficiency (EPI); PANZYTRAT for use in the treatment of EPI and pancreatic enzyme deficiency; CANASA for the treatment of ulcerative proctitis; and SALOFALK for the treatment of inflammatory bowel diseases, such as ulcerative colitis, ulcerative proctitis, and Crohn’s disease. The company was incorporated in 2007 and is based in Mont-Saint-Hilaire, Canada. Aptalis Pharma Canada Inc. operates as...

597 Bd Sir Wilfrid Laurier

Mont-Saint-Hilaire, QC J3H 4X8

Canada

Founded in 2007

875 Employees

Phone:

450-467-5138

Fax:

450-464-9979

Key Executives for Aptalis Pharma Canada Inc.

Aptalis Pharma Canada Inc. does not have any Key Executives recorded.

Aptalis Pharma Canada Inc. Key Developments

Aptalis Pharmaceutical Technologies Presents at BIO-Europe Spring 2015, Mar-10-2015 03:00 PM

Aptalis Pharmaceutical Technologies Presents at BIO-Europe Spring 2015, Mar-10-2015 03:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Aptalis Pharmaceutical Technologies Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 02:30 PM

Aptalis Pharmaceutical Technologies Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 02:30 PM. Venue: OVAL Lingotto, Turin, Italy.

Aptalis Pharma Inc., Forest Laboratories Inc. - M&A Call

To discuss the agreement to acquire Aptalis

Similar Private Companies By Industry

Company Name Region
Bristol-Myers Squibb Canada Co. Americas
MBVax Bioscience Inc. Americas
Zoetis Aquaculture Americas
Distribution Pharmaplus Inc. Americas
PlantForm Corporation Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aptalis Pharma Canada Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.